138 related articles for article (PubMed ID: 1376846)
61. Effect of isradipine on cardiopulmonary baroreflex function, regional blood flow, and vascular responsiveness in hypertensive patients.
Hirsch AT; Dzau VJ; Cutler SS; Levenson DJ; Creager MA
J Cardiovasc Pharmacol; 1992 Feb; 19(2):272-81. PubMed ID: 1376797
[TBL] [Abstract][Full Text] [Related]
62. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
Krusell LR; Jespersen LT; Schmitz A; Thomsen K; Pedersen OL
Hypertension; 1987 Dec; 10(6):577-81. PubMed ID: 2447016
[TBL] [Abstract][Full Text] [Related]
63. Isradipine in the treatment of mild to moderate essential hypertension.
Leary WP; Maharaj B; Van der Byl K
S Afr Med J; 1991 Oct; 80(7):322-3. PubMed ID: 1833834
[TBL] [Abstract][Full Text] [Related]
64. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.
Lopez LM; Santiago TM
Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246
[TBL] [Abstract][Full Text] [Related]
65. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
[TBL] [Abstract][Full Text] [Related]
66. [The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension].
Lepakhin VK; Ivleva AIa; Romashova MF; Udotova SA; Zubovskiĭ LG
Eksp Klin Farmakol; 1992; 55(6):24-6. PubMed ID: 1305868
[TBL] [Abstract][Full Text] [Related]
67. Long-term effects of isradipine on blood pressure and renal function.
Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
[TBL] [Abstract][Full Text] [Related]
68. Isradipine, catecholamines, and pheochromocytoma.
Januszewicz W; Wocial B; Chodakowska J; Feltynowski T; Lapiński M
Am J Hypertens; 1991 Nov; 4(11):916-7. PubMed ID: 1838694
[No Abstract] [Full Text] [Related]
69. [Isradipine-SRO: antihypertensive efficacy, central and peripheral hemodynamic effects in patients with hypertensive disease].
Podzolkov VI; Bartieva DM; Makolkin VI
Kardiologiia; 2003; 43(6):33-8. PubMed ID: 12891309
[TBL] [Abstract][Full Text] [Related]
70. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide.
Sihm I; Thygesen K; Krusell LR; Lederballe O
Blood Press; 2000; 9(6):346-54. PubMed ID: 11212064
[TBL] [Abstract][Full Text] [Related]
71. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg KJ
Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629
[TBL] [Abstract][Full Text] [Related]
72. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
[TBL] [Abstract][Full Text] [Related]
73. Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients.
Berg KJ; Holdaas H; Endresen L; Fauchald P; Hartmann A; Pran T; Solbu D
Nephrol Dial Transplant; 1991; 6(10):725-30. PubMed ID: 1836548
[TBL] [Abstract][Full Text] [Related]
74. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
[TBL] [Abstract][Full Text] [Related]
75. Effects of dihydropyridines and their combination with aspirin on blood pressure and circadian platelet activity in patients with essential hypertension.
Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N
Am J Hypertens; 1994 Jul; 7(7 Pt 2):46S-49S. PubMed ID: 7946179
[TBL] [Abstract][Full Text] [Related]
76. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension.
Baba T; Boku A; Ishizaki T; Sone K; Takebe K
Am Heart J; 1986 Mar; 111(3):552-7. PubMed ID: 3953366
[TBL] [Abstract][Full Text] [Related]
77. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479
[TBL] [Abstract][Full Text] [Related]
78. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension.
Brogden RN; Sorkin EM
Drugs; 1995 Apr; 49(4):618-49. PubMed ID: 7789292
[TBL] [Abstract][Full Text] [Related]
79. Isradipine in the treatment of hypertension: a clinical profile.
Vidt DG
Cleve Clin J Med; 1990; 57(8):677-84. PubMed ID: 2147874
[TBL] [Abstract][Full Text] [Related]
80. Antiatherosclerotic actions of isradipine.
Sinzinger H; Fitscha P
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S29-31. PubMed ID: 1376831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
